INDIA HR NEWS

  Harappa Education, the online learning platform, has introduced an invitation-only scholarship, the Harappa Learning Fellows. The first edition of the Learning Fellows offered complimentary access to a hand-picked online course from Ashoka X—online content from experts across the world presented by Ashoka University, and a selection of courses from Harappa Education. Fifteen leading higher educationists, prominent journalists and futuristic L&D leaders were invited to be part of the first edition of the fellowship. Shreyasi Singh, founder & CEO, Harappa Education, said, “These online courses are carefully chosen for their innovative curriculum and the experts who teach them.” The first edition of the scholarship offered one course from Ashoka X and any three courses of the individual’s choice from Harappa Education. The Ashoka X course on offer were: ‘Covering the World’ by Carol Giacomo; ‘The History and The Future of The University: Leadership and Change’ by Nicholas Di...

  Data network solutions provider  Sterlite Technologies  will hire about 300-400 professionals this fiscal for growth areas of 5G and wireless ecosystem and to support its plans to take services business global, Group CEO Anand Agarwal has said. The company will hire professionals with requisite experience as well as freshers for these growth areas. “We are strengthening our ecosystem that we speak about, our wireless and 5G ecosystem, so clearly on that front we are continuing with a strong level of hiring,” Agarwal told PTI. Part of the hiring is also in view of the company’s plans to take its services business global, in markets of the Middle East and Europe. “We are continuing on our strategic path and we are not letting the current slowdown in the economy or whatever is happening on COVID, to impact our overall long-term strategic roadmap,” he said. Sterlite Technologies (STL) expects to hire 300-400 people during the current financial year, he added. The company wi...

  Get ready for airport-like stations as  Indian Railways  is all set to introduce five ultra-modern stations in Bihar! The Rail Land Development Authority (RLDA) to redevelop a total of five railway stations in the state of Bihar under East Central Railway zone. The stations that will be redeveloped under the Public-Private Partnership (PPP) model as commercial hubs are Rajendra Nagar Terminal, Gaya, Muzaffarpur, Begusarai, and Singrauli. According to details shared by RLDA, these railway stations will be equipped with state-of-the-art amenities such as restaurants, food plaza, parking zones with links to station platforms, cafeteria, Internet, shopping areas as well as medical emergency booth among others in order to offer the best services and experiences to passengers. According to Ved Parkash Dudeja, Vice Chairman, RLDA, these five railway stations will be developed on the pattern of airports. Once the redevelopment works are over, these railway stations will provide...

  New research adds to the growing body of evidence that sofosbuvir and daclatasvir, a drug combination commonly used for the treatment of hepatitis C, can improve clinical outcomes in patients with moderate or severe Covid-19. Three studies, published in Journal of Antimicrobial Chemotherapy, researched the use of sofosbuvir and daclatasvir for the treatment of Covid-19. These three studies come from Iran, which has developed its own pill containing sofosbuvir and daclatasvir, and is in a position to test this in a large clinical trial as Iran is a massively impacted country, reporting some 2,500 cases and 200 deaths a day. "Despite the encouraging initial results, it is too early to reach a verdict. Larger, well-designed studies are required to confirm our results," said Shahin Merat, the lead author of one of the Journal of Antimicrobial Chemotherapy articles, from Tehran University in Iran. Currently no effective antiviral therapy has been found to treat Covid-19. The aim...

  The Russian government has reached out to India seeking a collaboration for manufacturing its COVID-19 vaccine Sputnik V' and conducting its phase 3 clinical trial here, sources said. According to government sources, the matter was discussed by the national expert group on vaccine administration for COVID-19 in its meeting held on August 22. Sputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology along with the Russian Direct Investment Fund (RDIF). The vaccine has not been tested in phase 3 or larger clinical trials. There has been scepticism in some quarters about limited data related to the efficacy of the vaccine. "The Russian government has reached out to the Indian government seeking a collaboration for manufacturing their COVID-19 vaccine, Sputnik V, and conducting its phase 3 trial here, a source in the government said. "The Department of Biotechnology (DBT) along with the Department of Health Research has been asked to l...

  Bad news keeps piling up for global workers in this pandemic-besotted year as more corporates announce their downsizing plans in order to mitigate risks of a slowing economy. Now global professional services company Accenture which has half-a-million employees worldwide plans to fire ‘low-performing’ workforce, as per reports. A report in the Australian Financial Review (AFR) first reported that the company is planning the desperate measure. The report cited an internal staff meeting by Accenture CEO Julie Sweet in mid-August. Notably, India which has the company’s largest pool at 2 lakh workers can witness the brunt of job cuts at the company. However, Accenture denied the same in a statement to news agency IANS. "Every year, as part of our performance process, we have conversations with our people about how they are performing, areas for improvement, their potential to progress, and whether they are a long term fit for Accenture," it said. "This year, across all part...